Article info

Download PDFPDF

Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study

Authors

  1. Correspondence to Dr Frank C Albers; frank{at}avillionllp.com
View Full Text

Citation

Chipps BE, Albers FC, Reilly L, et al
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study

Publication history

  • Received September 17, 2021
  • Accepted November 15, 2021
  • First published December 9, 2021.
Online issue publication 
December 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.